Lynx Equity raises Intel stock price target to $90 on margin outlook

The market is starting to price Intel less like a distressed turnaround and more like a levered manufacturing recovery story. The key second-order effect is that margin upside from fuller utilization matters more than top-line growth here: if the legacy nodes are genuinely saturated, incremental revenue drops through at a much higher rate than the market has modeled, which can re-rate the stock faster than consensus EPS revisions alone would suggest.

The bigger strategic implication is that a credible foundry path changes Intel's customer conversation from “can you execute?” to “can you guarantee capacity and geopolitical optionality?” That benefits domestic supply-chain beneficiaries around toolmakers, packaging, and US-based manufacturing ecosystems, while pressuring any competitor whose pitch relies on scarce leading-edge capacity or a cleaner execution narrative. It also raises the odds that Intel becomes a strategic asset in procurement decisions even before the economics are fully proven.

The contrarian risk is that this optimism is front-loading a multi-year recovery into a stock that has already moved sharply. Any slip in 18A/next-node timing, or evidence that utilization is being propped up by lower-margin mix, would compress multiple expansion quickly because the current debate is now about durability rather than direction. In that sense, the stock is more vulnerable to a guidance miss over the next 1-2 quarters than to a long-term thesis failure.

Net: the setup favors tactical longs on pullbacks rather than chasing strength outright. The path to upside likely runs through margin surprise and not just revenue beats, so the cleanest expression is a relative value trade against a higher-quality semis name rather than an unhedged directional bet.